Form 8-K - Current report:
SEC Accession No. 0001213900-25-015281
Filing Date
2025-02-19
Accepted
2025-02-19 16:01:25
Documents
14
Period of Report
2025-02-18
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0231568-8k_pmgc.htm   iXBRL 8-K 26553
2 PRESS RELEASE OF NORTHSTRIVE BIOSCIENCES DATED AS OF FEBRUARY 18, 2025 ea023156801ex99-1_pmgc.htm EX-99.1 12570
  Complete submission text file 0001213900-25-015281.txt   223122

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE elab-20250218.xsd EX-101.SCH 3027
4 XBRL LABEL FILE elab-20250218_lab.xml EX-101.LAB 34916
5 XBRL PRESENTATION FILE elab-20250218_pre.xml EX-101.PRE 22797
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0231568-8k_pmgc_htm.xml XML 3963
Mailing Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660
Business Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660 888-445-4886
PMGC Holdings Inc. (Filer) CIK: 0001840563 (see all company filings)

EIN.: 851399981 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41875 | Film No.: 25639777
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)